Skip to main content
GALECTIN THERAPEUTICS INC logo

GALECTIN THERAPEUTICS INC — Investor Relations & Filings

Ticker · GALT ISIN · US3632252025 LEI · 5299004HFYSAZM2ALW85 US Manufacturing
Open in API
Filings indexed 1,091 across all filing types
Latest filing 2012-05-30 Declaration of Voting R…
Country US United States of America
Listing US GALT

About GALECTIN THERAPEUTICS INC

https://galectintherapeutics.com/

Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for fibrotic diseases, chronic liver disease, and cancer. The company's therapeutic approach centers on inhibiting the galectin-3 protein, which is implicated in various inflammatory, fibrotic, and malignant conditions. Its lead drug candidate, belapectin (GR-MD-02), is a proprietary carbohydrate-based drug designed to bind to and inhibit galectin-3. The primary development program for belapectin is focused on treating non-alcoholic steatohepatitis (MASH) with cirrhosis, a serious liver disease with no currently approved therapies.

Recent filings

Filing Released Lang Actions
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes announcements of a director's bonus, amendments to bylaws, voting results from the annual meeting, and restated articles of incorporation. These items correspond to changes in board and management information, governance updates, and shareholder voting results. The document is not a full annual report, audit report, or earnings release. It contains detailed voting results, which aligns with Declaration of Voting Results & Voting Rights Announcements (DVA). It also includes amendments to bylaws, which could relate to governance, but the presence of voting results and director appointments is more specific to DVA. The document length is over 5,000 characters and contains substantive information, not just an announcement of a report. Therefore, the best classification is DVA (Declaration of Voting Results & Voting Rights Announcements).
2012-05-30 English
FORM 4
Director's Dealing
2012-05-25 English
FORM 4
Director's Dealing
2012-05-25 English
FORM 4
Director's Dealing
2012-05-25 English
FORM 3
Director's Dealing
2012-05-25 English
FORM 4
Director's Dealing
2012-05-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.